Pulmatrix logo

Pulmatrix Share Price Today

(NASDAQ: PULM)

Pulmatrix share price is $7.63 & ₹663.57 as on 6 Mar 2025, 2.30 'hrs' IST

$7.63

0.49

(6.86%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Pulmatrix share price in Dollar and Rupees. Guide to invest in Pulmatrix stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pulmatrix, along with analyst recommendations, forecasts, and comprehensive financials.

Pulmatrix share price movements

  • Today's Low: $7.28
    Today's High: $7.66

    Day's Volatility :4.97%

  • 52 Weeks Low: $1.55
    52 Weeks High: $10.40

    52 Weeks Volatility :85.1%

Pulmatrix (PULM) Returns

PeriodPulmatrix IncIndex (Russel 2000)
3 Months
35.04%
0.0%
6 Months
263.66%
0.0%
1 Year
301.58%
0.0%
3 Years
20.54%
-11.6%

Pulmatrix (PULM) Key Statistics

in dollars & INR

Previous Close
$7.14
Open
$7.3
Today's High
$7.6606
Today's Low
$7.28
Market Capitalization
$26.1M
Today's Volume
$13.1K
52 Week High
$10.4
52 Week Low
$1.55
Revenue TTM
$10.0M
EBITDA
$-7.3M
Earnings Per Share (EPS)
$-2.39
Profit Margin
-96.51%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-62.7%

How to invest in Pulmatrix Stock (PULM) from India?

It is very easy for Indian residents to invest directly in Pulmatrix from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pulmatrix stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pulmatrix or PULM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pulmatrix or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pulmatrix shares which would translate to 0.114 fractional shares of Pulmatrix as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pulmatrix, in just a few clicks!

Returns in Pulmatrix (PULM) for Indian investors in Rupees

The Pulmatrix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pulmatrix investment value today

Current value as on today

₹4,06,528

Returns

₹3,06,528

(+306.53%)

Returns from Pulmatrix Stock

₹3,01,579 (+301.58%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Pulmatrix (PULM)

-25%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Pulmatrix Stock from India on INDmoney has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Pulmatrix

  • Renaissance Technologies Corp

    2.99%

  • SBI Securities Co Ltd

    1.81%

  • BlackRock Inc

    1.50%

  • Geode Capital Management, LLC

    1.01%

  • Vanguard Group Inc

    0.96%

  • State Street Corp

    0.38%

Analyst Recommendation on Pulmatrix

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Pulmatrix(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pulmatrix Stock (PULM)

What analysts predicted

Upside of 31.06%

Target:

$10.00

Current:

$7.63

Insights on Pulmatrix Stock (Ticker Symbol: PULM)

  • Price Movement

    In the last 6 months, PULM stock has moved up by 281.5%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 5.88M → 366.0K (in $), with an average decrease of 75.0% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -5.81M → -2.58M (in $), with an average increase of 124.6% per quarter
  • PULM vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 23.1%

PULM Pulmatrix Financials in INR & Dollars

FY18Y/Y Change
Revenue
$153.0K
↓ 54.33%
Net Income
$-20.6M
↑ 13.88%
Net Profit Margin
-13.4K%
↓ 8050.02%
FY19Y/Y Change
Revenue
$7.9M
↑ 5069.93%
Net Income
$-20.4M
↓ 0.84%
Net Profit Margin
-257.79%
↑ 13182.08%
FY20Y/Y Change
Revenue
$12.6M
↑ 59.72%
Net Income
$-28.5M
↑ 39.84%
Net Profit Margin
-225.7%
↑ 32.09%
FY21Y/Y Change
Revenue
$5.2M
↓ 59.09%
Net Income
$-22.5M
↓ 21.08%
Net Profit Margin
-435.38%
↓ 209.68%
FY22Y/Y Change
Revenue
$6.1M
↑ 17.45%
Net Income
$-18.7M
↓ 16.8%
Net Profit Margin
-308.43%
↑ 126.95%
FY23Y/Y Change
Revenue
$7.3M
↑ 20.21%
Net Income
$-14.1M
↓ 24.59%
Net Profit Margin
-193.49%
↑ 114.94%
Q2 FY23Q/Q Change
Revenue
$1.8M
↑ 23.02%
Net Income
$-3.8M
↓ 11.48%
Net Profit Margin
-206.94%
↑ 80.65%
Q3 FY23Q/Q Change
Revenue
$1.8M
↓ 4.93%
Net Income
$-3.8M
↓ 1.1%
Net Profit Margin
-215.29%
↓ 8.35%
Q4 FY23Q/Q Change
Revenue
$2.2M
↑ 25.61%
Net Income
$-2.1M
↓ 44.81%
Net Profit Margin
-94.6%
↑ 120.69%
Q1 FY24Q/Q Change
Revenue
$5.9M
↑ 167.26%
Net Income
$825.0K
↓ 139.61%
Net Profit Margin
14.02%
↑ 108.62%
Q2 FY24Q/Q Change
Revenue
$1.6M
↓ 73.63%
Net Income
$-5.8M
↓ 804.36%
Net Profit Margin
-374.42%
↓ 388.44%
Q3 FY24Q/Q Change
Revenue
$366.0K
↓ 76.42%
Net Income
$-2.6M
↓ 55.48%
Net Profit Margin
-706.83%
↓ 332.41%
FY18Y/Y Change
Profit
$-12.8M
↑ 29.32%
FY19Y/Y Change
Profit
$-4.9M
↓ 61.48%
FY20Y/Y Change
Profit
$12.6M
↓ 356.01%
FY21Y/Y Change
Profit
$-10.2M
↓ 180.84%
FY22Y/Y Change
Profit
$6.1M
↓ 159.44%
FY23Y/Y Change
Profit
$-8.2M
↓ 235.4%
Q2 FY23Q/Q Change
Profit
$1.4M
↑ 27.87%
Q3 FY23Q/Q Change
Profit
$1.3M
↓ 5.48%
Q4 FY23Q/Q Change
Profit
$2.0M
↑ 50.26%
Q1 FY24Q/Q Change
Profit
$5.6M
↑ 181.39%
Q2 FY24Q/Q Change
Profit
$1.4M
↓ 75.21%
Q3 FY24Q/Q Change
Profit
$366.0K
↓ 73.69%
FY18Y/Y Change
Operating Cash Flow
$-16.8M
↑ 15.78%
Investing Cash Flow
$-19.0K
↓ 74.32%
Financing Cash Flow
$15.8M
↑ 13.46%
FY19Y/Y Change
Operating Cash Flow
$3.2M
↓ 119.27%
Investing Cash Flow
$-58.0K
↑ 205.26%
Financing Cash Flow
$17.7M
↑ 12.11%
FY20Y/Y Change
Operating Cash Flow
$-12.5M
↓ 486.47%
Investing Cash Flow
$-281.0K
↑ 384.48%
Financing Cash Flow
$21.0M
↑ 18.5%
FY21Y/Y Change
Operating Cash Flow
$-19.7M
↑ 58.03%
Investing Cash Flow
$-144.0K
↓ 48.75%
Financing Cash Flow
$43.5M
↑ 107.21%
FY22Y/Y Change
Operating Cash Flow
$-19.4M
↓ 1.88%
Investing Cash Flow
$-86.0K
↓ 40.28%
Financing Cash Flow
$1.2M
↓ 97.17%
Q2 FY23Q/Q Change
Operating Cash Flow
$-4.9M
↓ 0.49%
Investing Cash Flow
$-58.0K
↑ 0.0%
Financing Cash Flow
$0.0
↓ 100.0%

Pulmatrix Technicals Summary

Sell

Neutral

Buy

Pulmatrix is currently in a neutral trading position according to technical analysis indicators.

Pulmatrix (PULM) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pulmatrix Inc logo
8.53%
263.66%
301.58%
20.54%
-74.05%
Regeneron Pharmaceuticals, Inc. logo
-3.09%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
15.43%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
0.82%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-10.36%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pulmatrix Inc logo
NA
NA
0.0
0.0
-0.63
-0.19
NA
2.99
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pulmatrix Inc logo
Buy
$26.1M
-74.05%
NA
-96.51%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Pulmatrix

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.
Organization
Pulmatrix
Employees
22
CEO
Mr. Peter Ludlum CMA, MBA
Industry
Health Technology

Management People of Pulmatrix

NameTitle
Mr. Peter Ludlum CMA, MBA
Interim Chief Executive Officer
Dr. Alexander M. Klibanov Ph.D.
Founder

Important FAQs about investing in PULM Stock from India :

What is Pulmatrix share price today?

Pulmatrix share price today stands at $7.63, Open: $7.30 ; Previous Close: $7.14 ; High: $7.66 ; Low: $7.28 ; 52 Week High: $10.40 ; 52 Week Low: $1.55.

The stock opens at $7.30, after a previous close of $7.14. The stock reached a daily high of $7.66 and a low of $7.28, with a 52-week high of $10.40 and a 52-week low of $1.55.

Can Indians buy Pulmatrix shares?

Yes, Indians can invest in the Pulmatrix (PULM) from India.

With INDmoney, you can buy Pulmatrix at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pulmatrix at zero transaction cost.

How can I buy Pulmatrix shares from India?

It is very easy to buy Pulmatrix from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pulmatrix (PULM) be purchased?

Yes, you can buy fractional shares of Pulmatrix with INDmoney app.

What are the documents required to start investing in Pulmatrix stocks?

To start investing in Pulmatrix, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pulmatrix Stock (PULM)?

Today’s highest price of Pulmatrix (PULM) is $7.66.

Today’s lowest price of Pulmatrix (PULM) is $7.28.

What is today's market capitalisation of Pulmatrix?

Today's market capitalisation of Pulmatrix PULM is 26.1M

What is the 52 Week High and Low Range of Pulmatrix Stock (PULM)?

  • 52 Week High

    $10.40

  • 52 Week Low

    $1.55

What are the historical returns of Pulmatrix (PULM)?

  • 1 Month Returns

    8.53%

  • 3 Months Returns

    263.66%

  • 1 Year Returns

    301.58%

  • 5 Years Returns

    -74.05%

Who is the Chief Executive Officer (CEO) of Pulmatrix ?

Mr. Peter Ludlum CMA, MBA is the current Chief Executive Officer (CEO) of Pulmatrix.